The Signature Suite

One Platform.
Built in Layers.

Each product addresses a distinct dimension of human complexity — chronic illness, psychological violence, signal processing, cognition, and the foundational intelligence layer beneath them all. Biomarkers are the method. Human sovereignty is the mission.

SymbAIo platform architecture

One ecosystem. Infinite understanding.

iMpatient™

Your health. Your signal. Your sovereignty

Testing — Launching May 30, 2026

A patient-first health intelligence platform that transforms wearable biomarker data into traceable, correlative blueprints. Born from two decades of lived experience navigating a healthcare system that wasn't designed to listen. Launching May 30, 2026

Core Capabilities

  • Wearable biomarker integration and pattern recognition
  • Traceable correlative health blueprints
  • Patient-controlled data sovereignty
  • Longitudinal health narrative construction
  • Provider-ready insight summaries

K@te™

Awareness before crisis

In Development — Launching November 2026

K@te™ is a contextual safety companion designed for survivors of psychological violence, coercive control, and people navigating unsafe environments. Psychological violence often leaves no visible marks — but the body keeps the score. K@te™ reads the signals your body is already sending: elevated stress biomarkers, disrupted HRV, vagus nerve dysregulation, behavioral pattern shifts, and environmental context changes. It surfaces awareness — not alerts, not alarms — giving the individual a private, traceable understanding of what their nervous system already knows. K@te™ is not a panic button. It is not surveillance. It is a quiet, sovereign companion that helps people see what they already feel. Launching November 2026

Core Capabilities

  • Stress biomarker and HRV pattern recognition
  • Vagus nerve dysregulation detection (Pulsetto / Nurosym integration)
  • Behavioral pattern shift identification
  • Environmental and contextual safety mapping
  • Sovereign, private awareness — no alerts sent to anyone but the user
  • Trauma-informed, non-intrusive design

mønk™

The quiet architecture beneath

BETA

The foundational operating layer that powers the entire Signature Suite. Privacy-first, non-reductive intelligence architecture designed to hold human complexity without simplifying it. Currently in BETA, powering test versions of iMpatient™ and K@te™

Core Capabilities

  • Privacy-first data architecture
  • Non-reductive intelligence processing
  • Cross-product data orchestration
  • Adaptive learning without surveillance
  • Human-complexity-native design
Integrates With

Wearable & Platform Integrations

iMpatient™ and K@te™ connect to the devices and health platforms already in your life — pulling biomarker data from across your ecosystem into a single correlative intelligence layer you control. For iMpatient™, that means health clarity. For K@te™, that means safety awareness.

Health Platforms

Apple Health

Activity, heart rate, sleep, vitals, nutrition

Google Health

Activity, heart rate, sleep, vitals

Wearables

Oura

Sleep architecture, HRV, temperature, activity

Garmin

Activity, heart rate, stress, sleep, SpO2

Fitbit

Activity, heart rate, sleep, stress management

Whoop

Strain, recovery, sleep, HRV

Withings

Blood pressure, weight, sleep, SpO2

Neuromodulation

Pulsetto

Vagus nerve stimulation session data

Nurosym

Vagus nerve stimulation and bioelectronic data. Critical for K@te™ — vagus nerve data provides direct nervous system intelligence, mapping the body's stress and safety responses in real time

iMpatient™ integrates with leading wearable and health platforms at launch

On the Horizon

Expanding the Ecosystem

As the core platform matures, SymbAIo will expand into signal processing and cognitive wellness — extending the mønk™ intelligence layer into new dimensions of human complexity.

USPTO Patent Review

iMpulSIM™

Signals before they become noise

A signal processing engine that identifies meaningful patterns in complex data streams before they become actionable crises. Early warning, not late reaction

Concept Phase

NeuroSPARK™

Cognition, illuminated

Cognitive wellness mapping at the intersection of mental load, biological signals, and environmental context. Understanding how you think, not just what you think

Intelligence Infrastructure

mønk™ is SymbAIo's proprietary intelligence engine — the architecture beneath every product in the Signature Suite. The AI infrastructure powering mønk™ runs on Claude by Anthropic, our AI provider of choice — selected for its alignment with safety, interpretability, and non-reductive human understanding. Claude powers the custom AI tools we design for SymbAIo Labs clients, from iMpatient™ to enterprise engagements. It surfaces patterns and correlations. It never makes decisions for the user. It illuminates — the human decides.

Interested in the technical architecture?

Our Investor Portal contains detailed technical documentation, product roadmaps, and architectural specifications.

Access Investor Portal